GSK Plc-Novartis deal: Focus on GSK Healthcare

| Updated on March 27, 2018 Published on March 27, 2018


UK-based GlaxoSmithKline Plc will examine selling its stake in the Indian consumer health subsidiary to fund its $13-billion Novartis deal, says a Bloomberg report. The strategic review of its 72.5 per cent stake in GlaxoSmithKline Consumer Healthcare is expected to be closed by 2018 end. Brand Horlicks will also be part of the process, GSK said. However, there can be no assurance that the review process will result in any transaction, the pharma major further clarified.

Published on March 27, 2018
This article is closed for comments.
Please Email the Editor